the changing role of autosct in the treatment of multiple myeloma in the era of novel agents
Published 1 year ago • 98 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
4:21
an insight into the changing role of transplantation for myeloma & lymphoma in the era of car-t
-
2:03
the evolving role of transplantation in multiple myeloma in the age of novel immunotherapeutics
-
2:22
the benefit of autologous transplantation in the era of novel agents in multiple myeloma
-
4:03
novel technologies in multiple myeloma and how these are changing the field
-
4:04
the future of myeloma treatment and the possibility of cure
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
2:30
a new era of treatment for multiple myeloma
-
2:39
the role of tandem transplantation in multiple myeloma & how this may be impacted by novel agents
-
3:24
novel agents for the management of r/r myeloma
-
1:53
the future of multiple myeloma treatment
-
2:39
a look into the future of multiple myeloma treatment: t-cell redirecting therapies vs autohsct
-
2:49
how is the genomic landscape of multiple myeloma changing?
-
1:11
advances that have been made in the molecular characterization of multiple myeloma
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
1:54
the future of multiple myeloma treatment
-
1:01
car-t: myeloma toxicities
-
1:59
the growing importance of celmods in the treatment of r/r multiple myeloma
-
2:16
the utility of next-generation sequencing for multiple myeloma
-
2:17
cilta-cel: a paradigm shift in the treatment of multiple myeloma